Varenicline and Bupropion for Smoking Cessation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

506

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Smoking
Interventions
DRUG

Varenicline

varenicline - 1 mg bid for 12 weeks

DRUG

placebo

placebo for 12 weeks

DRUG

bupropion SR

bupropion sr - 150 mg bid for 12 weeks

Trial Locations (3)

54601

Franciscan Skemp Hospital, La Crosse

55414

University Of Minnesota, Minneapolis

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

University of Minnesota

OTHER

lead

Mayo Clinic

OTHER